Holcomb joins list of GOP officials opposed to Medicaid cuts
Indiana Gov. Eric Holcomb on Monday joined a growing chorus of Republicans who are asking the GOP-led Congress to spare Medicaid funding as they go about repealing Obamacare.
Indiana Gov. Eric Holcomb on Monday joined a growing chorus of Republicans who are asking the GOP-led Congress to spare Medicaid funding as they go about repealing Obamacare.
The hospital system plans to tear down a two-story hotel near its Indianapolis flagship campus and build a training facility for simulating situations in acute care.
The United State's biggest advocacy group for doctors came out against House Republicans’ legislation, adding to growing opposition from the country’s top trade groups for physicians and hospitals.
Share of Eli Lilly and Co. and numerous other drug industry stocks fell Tuesday morning after the president sent a tweet promising to lower medicine costs for American people.
House committees planned to begin voting on the 123-page legislation Wednesday, launching what could be the year's defining battle in Congress and capping seven years of Republican vows to repeal the troubled 2010 law.
Getting elected mayor requires fine-tuned political instincts. Sometimes, those instincts say it’s time to leave a high-level job at the biggest company in town.
Hutchison China MediTech Ltd., the biotechnology company that has a partnership with Eli Lilly and Co., on Friday reported positive late-stage results for its drug to treat colorectal cancer.
Indiana health care consultant Seema Verma was approved by the Finance Committee on a 13-12 party-line vote.
Just when I thought getting through chemo was a tough challenge, I faced another—six days in the hospital to remove and replace my cancerous bladder. I hope the lessons I learned will make me a better journalist.
Alzheimer’s disease is rewriting the rules of drug discovery, with companies like Eli Lilly and others abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.
MDwise said it could not reach an agreement with the Indiana Family and Social Services Administration’s Office of Medicaid Policy and Planning over payment rates for the Hoosier Care Connect program.
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Politico has reported that the Trump White House was not impressed with a 2016 column in which local Republican strategist Marcus Barlow said Trump was “offensive and ignorant” but not a racist.
The county-owned hospital system has more than $100 million in ongoing projects, making it one of the biggest eras of growth in the history of Riverview, which opened its Noblesville hospital in 1951.
Indiana House Republicans are taking the unusual step of reassigning an abortion bill to the same panel that narrowly approved it last week.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Indiana health care consulting executive Seema Verma on Thursday testified before the Senate Finance Committee on her nomination to lead the Centers for Medicare and Medicaid Services, or CMS.
Indianapolis-based Anthem Inc. on Wednesday won a court ruling blocking Cigna Corp. from terminating a proposed merger between the health insurers until a judge could weigh arguments over the faltering deal at an April 10 hearing.
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
The collapse of one potential mega-merger and the uncertain future of the other could hurt shoppers on the Affordable Care Act exchanges next year by leaving them with even fewer options and potentially higher prices.